RXST: RxSight Company Sales Revenue

RxSight, Inc. (RXST) maintains its status as a global monopolist by implementing laser vision adjustment technology following cataract surgery. The company's commercial revenue on this chart demonstrates operational resilience, where 0.12 serves as the current metric level. Revenues are based on the sale of innovative LAL lenses, while exceptional pricing power allows the company to maintain premium pricing due to the product's uniqueness.

Revenue and Sales Volume: RxSight (RXST) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for RxSight (RXST)

- current price and projected stock value:

Share Price RxSight Ophthalmic|RXST - Consensus Target

- market capitalization information:

Market Value RxSight, Inc.|RXST - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share RxSight|RXST - Book Capitalization|Market-to-Book Ratio rxsight.com|RXST - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

RXST - Net Income|Expected Net Income RxSight, Inc.|RXST - P/E Multiple|Projected Price to Earnings Ratio rxsight.com|RXST - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple RxSight, Inc.|RXST - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) RxSight|RXST - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months rxsight.com|RXST - Earnings per share growth in current year|Net earnings per share change forecast for next year RxSight, Inc.

- company sales and revenue statistics:

RXST - Company Revenue|Company Future Sales Volume RxSight Ophthalmic|RXST - P/S Multiple|Market Cap to Future Revenue Ratio RxSight, Inc.

Summary company analysis:RXST RxSight Ophthalmic

Professional managers utilize fundamental metrics to filter assets based on their scaling potential. This indicator measures the average daily operating cash flow, reflecting the business's monetization rate. For RxSight, Inc. (RXST), this flow is generated through the sale of high-margin Light Adjustable Lenses (LAL). Revenue growth confirms the market adoption of innovations in ophthalmology. By analyzing the company's sales volume, investors assess the sustainability of its expansion drivers.

Key competitors